Feed/Companies/Supira Medical

Supira Medical

As of 14 Oct 2026, Supira Medical has raised $120M across 1 verified round on record; latest: $120M Series E led by Novo Holdings and Qatar Investment Authority (QIA), announced 26 Mar 2025.

BUILT ON

Visit site

Supira Medical develops a next-generation percutaneous ventricular assist device (pVAD) aimed at high-risk patients undergoing interventional heart procedures.

supiramedical.comLinkedInLos Gatos, CA

LATEST ROUND

Series E

$120M · 2025-03-26

RAISED ON RECORD · USD

$120M

across 1 verified round

INVESTORS

2 leads

SOURCES

from 2 publishers

Feed/Companies

Company

Every round on record, with the sources behind each and the investors on them.

BUILT ON

Series E

$120M · 2025-03-26

[ HISTORY ]

led by Novo Holdings, Qatar Investment Authority (QIA)

Round	Amount	Announced	Lead	Buzz
Series E [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$120M	2025-03-26	Novo Holdings, Qatar Investment Authority (QIA)	No recent discussion
2 sources [ VERIFIED · CORRECTED ] read against 2 sources Lead added Qatar Investment Authority (QIA) · supiramedical.com The release’s Los Gatos dateline is not an explicit headquarters statement; headquarters is therefore not stated.

Supira Medical

Company

Rounds

Sources

Profile

Investors

Supira Medical

Rounds

Profile

Sources

Series E$120M2025-03-262 sources

Investors

Series E$120M2025-03-268 investors